4//SEC Filing
Newman Michael James 4
Accession 0001493152-21-018904
CIK 0001857044other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 5:00 PM ET
Size
5.5 KB
Accession
0001493152-21-018904
Insider Transaction Report
Form 4
Newman Michael James
DirectorCSO and Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2021-08-04+290,000→ 290,000 totalExercise: $8.87Exp: 2031-08-04→ Common Stock (290,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on August 4, 2022 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001876315
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 5:00 PM ET
- Size
- 5.5 KB